{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:29:41Z","timestamp":1792549781632,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejpb.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T03:55:37Z","timestamp":1678852537000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Exploring temozolomide encapsulated PEGylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies"],"prefix":"10.1016","volume":"186","author":[{"given":"Tejashree","family":"Waghule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Laxmi Swetha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranendra","family":"Narayan Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Singhvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 SUPPL. 13","key":"10.1016\/j.ejpb.2023.03.004_b0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0093-7754(01)90070-3","article-title":"Future directions for temozolomide therapy","volume":"28","author":"Yung","year":"2001","journal-title":"Semin Oncol."},{"issue":"6","key":"10.1016\/j.ejpb.2023.03.004_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines8060151","article-title":"Considering the experimental use of Temozolomide in glioblastoma research","volume":"8","author":"Herbener","year":"2020","journal-title":"Biomedicines."},{"key":"10.1016\/j.ejpb.2023.03.004_b0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jconrel.2021.07.003","article-title":"Temozolomide nano enabled medicine : promises made by the nanocarriers in glioblastoma therapy","volume":"336","author":"Yasaswi","year":"2021","journal-title":"J Control Release."},{"issue":"9","key":"10.1016\/j.ejpb.2023.03.004_b0020","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1080\/10717544.2016.1189465","article-title":"Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?","volume":"23","author":"Qu","year":"2016","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2023.03.004_b0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/01616412.2015.1133025","article-title":"Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: A biophysical and cell culture evaluation","volume":"38","author":"Ananta","year":"2016","journal-title":"Neurol Res."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2023.03.004_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijpharm.2013.02.038","article-title":"Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations","volume":"447","author":"Serrano","year":"2013","journal-title":"Int J Pharm."},{"key":"10.1016\/j.ejpb.2023.03.004_b0035","series-title":"Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids","first-page":"165","article-title":"Pharmacokinetics and biodistribution of the nanoparticles","author":"Raza","year":"2017"},{"issue":"12","key":"10.1016\/j.ejpb.2023.03.004_b0040","first-page":"1","article-title":"Liposomal Formulations in Clinical Use : An Updated Review development","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics."},{"issue":"7","key":"10.1016\/j.ejpb.2023.03.004_b0045","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.nano.2018.05.021","article-title":"Lipid based nanocarriers : a translational perspective","volume":"14","author":"Mishra","year":"2018","journal-title":"Nanomed. Nanotechnol., Biol Med."},{"key":"10.1016\/j.ejpb.2023.03.004_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.113771","article-title":"Insights of lyotropic liquid crystals in topical drug delivery for targeting various skin disorders","volume":"315","author":"Rapalli","year":"2020","journal-title":"J Mol Liq."},{"key":"10.1016\/j.ejpb.2023.03.004_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111940","article-title":"Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach","volume":"141","author":"Waghule","year":"2021","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.ejpb.2023.03.004_b0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2147\/IJN.S188335","article-title":"Liquid crystalline assembly for potential combinatorial chemo \u2013 herbal drug delivery to lung cancer cells","volume":"14","author":"Abdelaziz","year":"2019","journal-title":"Int J Nanomedicine."},{"key":"10.1016\/j.ejpb.2023.03.004_b0065","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.2147\/IJN.S111736","article-title":"biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells : in vitro and in vivo studies","volume":"11","author":"May","year":"2016","journal-title":"Int J Nanomedicine."},{"key":"10.1016\/j.ejpb.2023.03.004_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.118724","article-title":"Quality by design assisted optimization of temozolomide loaded PEGylated lyotropic liquid crystals: Investigating various formulation and process variables along with in-vitro characterization","volume":"352","author":"Waghule","year":"2022","journal-title":"J Mol Liq."},{"key":"10.1016\/j.ejpb.2023.03.004_b0075","first-page":"1","article-title":"Exploring microfluidics and membrane extrusion for the formulation of temozolomide-loaded liposomes: investigating the effect of formulation and process variables","author":"Waghule","year":"2022","journal-title":"J Liposome Res."},{"issue":"559","key":"10.1016\/j.ejpb.2023.03.004_b0080","first-page":"1","article-title":"Metformin-encapsulated liposome delivery system: An effective treatment approach against breast cancer","volume":"11","author":"Shukla","year":"2019","journal-title":"Pharmaceutics."},{"issue":"36","key":"10.1016\/j.ejpb.2023.03.004_b0085","first-page":"1","article-title":"Evaluation of Extrusion Technique for Nanosizing Liposomes","volume":"8","author":"Gim","year":"2016","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.ejpb.2023.03.004_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.apsb.2014.12.001","article-title":"In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting","volume":"5","author":"Nasr","year":"2015","journal-title":"Acta Pharm Sin B."},{"key":"10.1016\/j.ejpb.2023.03.004_b0095","series-title":"Organic Materials as Smart Nanocarriers for Drug Delivery","first-page":"471","article-title":"Lyotropic liquid crystal nanoparticles: A novel improved lipidic drug delivery system","author":"Singhvi","year":"2018"},{"issue":"29","key":"10.1016\/j.ejpb.2023.03.004_b0100","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1016\/j.biomaterials.2012.06.056","article-title":"Paclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapy","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials."},{"key":"10.1016\/j.ejpb.2023.03.004_b0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and zeta potential - What they are and what they are not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J Control Release."},{"key":"10.1016\/j.ejpb.2023.03.004_b0110","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.2147\/IJN.S124264","article-title":"Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral Candida albicans","volume":"12","author":"Zhang","year":"2017","journal-title":"Int J Nanomedicine."},{"key":"10.1016\/j.ejpb.2023.03.004_b0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.steroids.2015.05.012","article-title":"Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis","volume":"101","author":"Pradhan","year":"2015","journal-title":"Steroids."},{"issue":"1","key":"10.1016\/j.ejpb.2023.03.004_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/acph-2016-0003","article-title":"Microscopic methods in analysis of submicron phospholipid dispersions","volume":"66","author":"Placzek","year":"2016","journal-title":"Acta Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2023.03.004_b0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/08982104.2020.1748648","article-title":"Design of temozolomide-loaded proliposomes and lipid crystal nanoparticles with industrial feasible approaches: comparative assessment of drug loading, entrapment efficiency, and stability at plasma pH","volume":"31","author":"Waghule","year":"2020","journal-title":"J Liposome Res."},{"key":"10.1016\/j.ejpb.2023.03.004_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.119848","article-title":"UV spectroscopic method for estimation of temozolomide : Application in stability studies in simulated plasma pH, degradation rate kinetics, formulation design, and selection of disso","volume":"258","author":"Waghule","year":"2021","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc."},{"key":"10.1016\/j.ejpb.2023.03.004_b0135","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00217-011-1429-5","article-title":"PEG-coated lyophilized proliposomes : preparation, characterizations and in vitro release evaluation of vitamin E","volume":"232","author":"Zhao","year":"2011","journal-title":"Eur Food Res Technol."},{"key":"10.1016\/j.ejpb.2023.03.004_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118310","article-title":"UV spectrophotometric method for simultaneous estimation of betamethasone valerate and tazarotene with absorption factor method : Application for in-vitro and ex-vivo characterization of lipidic nanocarriers for topical delivery","volume":"235","author":"Mahmood","year":"2020","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc."},{"key":"10.1016\/j.ejpb.2023.03.004_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/204925","article-title":"Evaluation of the DDSolver software applications","volume":"2014","author":"Zuo","year":"2014","journal-title":"Biomed Res Int."},{"issue":"3","key":"10.1016\/j.ejpb.2023.03.004_b0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: An add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.ejpb.2023.03.004_b0155","first-page":"340","article-title":"Formulation development and evaluation of temozolomide loaded hydrogenated soya phosphatidylcholine liposomes for the treatment of brain cancer","volume":"9","author":"Patel","year":"2016","journal-title":"Asian J Pharm Clin Res."},{"key":"10.1016\/j.ejpb.2023.03.004_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105438","article-title":"Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition","volume":"152","author":"Rapalli","year":"2020","journal-title":"Eur J Pharm Sci."},{"key":"10.1016\/j.ejpb.2023.03.004_b0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2019.02.013","article-title":"Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin","volume":"560","author":"Bapat","year":"2019","journal-title":"Int J Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2023.03.004_b0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5582\/ddt.2015.01016","article-title":"Liposome encapsulated of temozolomide for the treatment of glioma tumor : preparation, characterization and evaluation","volume":"9","author":"Gao","year":"2015","journal-title":"Drug Discov Ther."},{"key":"10.1016\/j.ejpb.2023.03.004_b0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2016.08.033","article-title":"Development of risperidone liposomes for brain targeting through intranasal route","volume":"163","author":"Narayan","year":"2016","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2023.03.004_b0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/10826076.2018.1511803","article-title":"A simplified and sensitive validated RP-HPLC method for determination of temozolomide in rat plasma and its application to a pharmacokinetic study","volume":"41","author":"Khosa","year":"2018","journal-title":"J Liq Chromatogr Relat Technol."},{"issue":"4","key":"10.1016\/j.ejpb.2023.03.004_b0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10717541003667822","article-title":"Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation","volume":"17","author":"Tang","year":"2010","journal-title":"Drug Deliv."},{"issue":"11","key":"10.1016\/j.ejpb.2023.03.004_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11110610","article-title":"Development of injectable PEGylated liposome encapsulating disulfiram for colorectal cancer treatment","volume":"11","author":"Najlah","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2023.03.004_b0195","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2147\/IJN.S337130","article-title":"Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes","volume":"17","author":"Hegazy","year":"2022","journal-title":"Int J Nanomedicine."},{"key":"10.1016\/j.ejpb.2023.03.004_b0200","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biomaterials.2016.07.037","article-title":"PEGylated squalenoyl-gemcitabine nanoparticles for thetreatment of glioblastoma","volume":"105","author":"Gaudin","year":"2017","journal-title":"Biomaterials."},{"issue":"14","key":"10.1016\/j.ejpb.2023.03.004_b0205","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1021\/acs.langmuir.6b04423","article-title":"Influence of Cubosome Surface Architecture on its Cellular Uptake Mechanism","volume":"33","author":"Deshpande","year":"2017","journal-title":"Langmuir."},{"issue":"1","key":"10.1016\/j.ejpb.2023.03.004_b0210","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1039\/C6NR07353K","article-title":"Effect of partial PEGylation on particle uptake by macrophages","volume":"9","author":"Sanchez","year":"2017","journal-title":"Nanoscale."},{"issue":"8","key":"10.1016\/j.ejpb.2023.03.004_b0215","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/nano11081963","article-title":"Size-dependent internalization efficiency of macrophages from adsorbed nanoparticle-based monolayers","volume":"11","author":"Petithory","year":"2021","journal-title":"Nanomaterials."},{"key":"10.1016\/j.ejpb.2023.03.004_b0220","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jcis.2019.06.045","article-title":"Cellular uptake of self-assembled phytantriol-based hexosomes is independent of major endocytic machineries","volume":"553","author":"Rodrigues","year":"2019","journal-title":"J Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2023.03.004_b0225","first-page":"2111","article-title":"Improvement of Biodistribution and Therapeutic Index via Increase of Polyethylene Glycol on Drug-carrying Liposomes in an HT-29 \/ luc Xenografted Mouse Model","volume":"2120","author":"Chow","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejpb.2023.03.004_b0230","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acsmedchemlett.8b00018","article-title":"Strategy for Extending Half-life in Drug Design and Its Significance","volume":"9","author":"Gunaydin","year":"2018","journal-title":"ACS Med Chem Lett."},{"issue":"1","key":"10.1016\/j.ejpb.2023.03.004_b0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanovl","year":"1990","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.ejpb.2023.03.004_b0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil \u00ae \u2014 The fi rst FDA-approved nano-drug : Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release."},{"key":"10.1016\/j.ejpb.2023.03.004_b0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jddst.2016.02.009","article-title":"Trans resveratrol loaded DSPE PEG 2000 coated liposomes : An evidence for prolonged systemic circulation and passive brain targeting","volume":"33","author":"Rajamanickam","year":"2016","journal-title":"J Drug Deliv Sci Technol."},{"key":"10.1016\/j.ejpb.2023.03.004_b0250","first-page":"445","article-title":"Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles","volume":"6","author":"Tian","year":"2011","journal-title":"Int J Nanomedicine."},{"key":"10.1016\/j.ejpb.2023.03.004_b0255","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/ijms18061249","article-title":"Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes","volume":"18","author":"Cataldi","year":"2017","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.ejpb.2023.03.004_b0260","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle \u2013 liver interactions : Cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J Control Release."},{"issue":"4","key":"10.1016\/j.ejpb.2023.03.004_b0265","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1023\/A:1018918623658","article-title":"Distinction Between the Depletion of Opsonins and the Saturation of Uptake in the Dose-Dependent Hepatic Uptake of Liposomes","volume":"10","author":"Harashima","year":"1993","journal-title":"Pharm Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:50:29Z","timestamp":1760547029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":53,"alternative-id":["S0939641123000644"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.03.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring temozolomide encapsulated PEGylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}